Question 1

What is the catalog number for Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene?

Accepted Answer

The catalog number for Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene is sc-358584.

Question 2

What sizes are available for Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene?

Accepted Answer

Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene is available in the following size(s): 10 mg.

Question 3

Is Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene in stock?

Accepted Answer

Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Trifluoromethylthio-3- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl) -benzene

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Cytokeratin, pan (Epithelial Marker) (KRTH/1576R + KRTL/1577R), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

MART-1 / Melan-A / MLANA (Melanoma Marker) (rMLANA/788), CF740 conjugate, 0.1mg/mL

C1QA / Complement C1q A-Chain (C1QA/2956), CF647 conjugate, 0.1mg/mL

Tyrosinase (T311), CF594 conjugate, 0.1mg/mL

CD43 (T-Cell Marker) (SPN/2049R), CF640R conjugate, 0.1mg/mL